Genomics Market to Grow at a CAGR of 10.20% During 2026-2035, Driven by the Rising Incidence of Genetic Disorders Across the Global

Genomics Market Overview

Genomics is the scientific study of genomes, the complete set of an organism’s DNA, including all its genes. It involves sequencing, analyzing, and interpreting genetic information to understand gene functions, variations, and interactions. Genomics plays a crucial role in advancing personalized medicine, disease research, and biotechnology. The market encompasses technologies and services related to genome sequencing, analysis, and applications. It is driven by growing demand for precision medicine, declining sequencing costs, and increasing research funding. Innovations in next-generation sequencing and bioinformatics are expanding market opportunities globally, fostering advancements in healthcare, agriculture, and pharmaceuticals.

Key Findings

• Approximately 100,000 individuals in the United  States are affected by sickle cell disease (SCD). This substantial patient base is accelerating advancements in genomic research and personalized therapies, thereby propelling growth in the genomics market.
• In February 2025, BioAro launched  PanOmiQ, an AI-driven whole genome sequencing platform delivering ultra-fast, accurate analysis in under two hours. This breakthrough enhanced precision medicine accessibility, accelerating market growth by enabling real-time genomic insights globally.
• One of the major market trends is the strategic partnership between HDR UK and GA4GH to unify genomic and health data standards. For instance, in March 2024, this collaboration  aimed to accelerate responsible data sharing, boosting precision medicine and market growth.

Genomics Market Demand Drivers

Technological advancements in data standardization and expanded access to comprehensive genomic datasets are key factors driving the growth in the market. In March 2025, the introduction  of the ‘Refget Sequence Collections’ tool by the University of Virginia enhanced the accuracy and reproducibility of genomic analyses, thereby, accelerating biomedical research. Furthermore, in January 2025, India’s GenomeIndia  initiative made 10,000 whole genome sequences accessible globally, fostering advancements in personalized medicine and biotechnology. Such milestones are poised to significantly drive market expansion in the forecast period.

Genomics Market Segmentation Analysis

Sequencing Segment is Anticipated to Lead the Market Share by Technology

Some of the technologies involved in the genomics market include sequencing, PCR, flow cytometry, microarrays, and others. Among these, sequencing is expected to hold a significant share due to its wide use in genomics, personalized medicine, and diagnostics. In March 2024, the World Health Organization launched  new guidance endorsing targeted next-generation sequencing (NGS) for detecting drug-resistant tuberculosis, highlighting sequencing’s crucial role in rapid, accurate diagnosis. WHO’s TB sequencing portal, containing over 56,000 sequences, demonstrated the growing importance and scalability of sequencing technology, reinforcing its position as the key growth driver in diagnostic markets.

The market report also offers insights based on the offering, application, end user, and region.

Genomics Market: Competitive Landscape

• In September 2024, Illumina, Inc., founded  in 1998 and headquartered in San Diego, California, announced the establishment of a global capability center in Bengaluru, India. This expansion was intended to support the next-generation sequencing technologies, advancing genomics applications to address public health challenges such as infectious diseases and cancer. Illumina’s presence enhances access to genomic sequencing, training, and research, solidifying its pivotal role in the global genomics market.
• In February 2025, F. Hoffmann La Roche  unveiled its novel Sequencing by Expansion (SBX) technology. This breakthrough next-generation sequencing platform offers ultra-rapid, high-throughput, and flexible DNA sequencing capabilities. Roche’s innovative SBX technology significantly accelerates genomic research and clinical diagnostics, reinforcing its leadership in genomics and expanding its impact on decoding complex diseases such as cancer and neurodegenerative disorders.
• Other players involved in the market include Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen, Agilent Technologies, Inc., Revvity, Charles River Laboratories, Bio-Rad Laboratories, Inc., and Becton, Dickinson and Company.

Genomics Market Analysis by Region

North America is Projected to Lead the Market Share

The market segmentation by region includes North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is likely to have a substantial share in the genomics market, driven by advanced manufacturing and technological innovations. In 2024, Complete Genomics  expanded its United States manufacturing footprint with new facilities in San Jose and Framingham, enhancing supply chain reliability and accelerating next-generation sequencing solutions for regional customers.

Key Offerings of the Report

• The EMR report gives an overview of the market for genomics for the period (2019-2025) and (2026-2035). 
• The report also offers historical (2019-2025) and forecast (2026-2035) market information for the offering, technology, application, end user, and region of the market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790